About Glyconics
Glyconics is a company based in Cardiff (United Kingdom) founded in 2013. Glyconics has raised $2.02 million across 2 funding rounds from investors including UK Research and Innovation, WealthClub and Deepbridge Capital. The company has 2 employees as of March 31, 2022. Glyconics operates in a competitive market with competitors including Respiratory Motion, Vitalograph, Sonavi Labs, Caltech Innovations and Cambridge Respiratory Innovations, among others.
- Headquarter Cardiff, United Kingdom
- Employees 2 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Glyconics Limited
- Date of Incorporation 22 Oct, 2013
- Jurisdiction NORWICH, NORFOLK, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.02 M (USD)
in 2 rounds
-
Latest Funding Round
$2.02 M (USD), Seed
Nov 18, 2021
-
Investors
UK Research and Innovation
& 3 more
-
Employee Count
2
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Glyconics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Glyconics
Glyconics has successfully raised a total of $2.02M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.02 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Glyconics
Glyconics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include UK Research and Innovation, WealthClub and Deepbridge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deepbridge Capital is focused on tax-efficient investment opportunities.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Offers tax-efficient investments and portfolios for high net worth individuals.
|
Locked | Locked | Locked |
Investor details for Glyconics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Glyconics
Investment portfolio details for Glyconics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Glyconics
Detailed financials for Glyconics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glyconics Comparisons
Peer comparison for Glyconics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Glyconics
Glyconics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Respiratory Motion, Vitalograph, Sonavi Labs, Caltech Innovations and Cambridge Respiratory Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive devices for respiratory volume monitoring are developed and commercialized.
|
|
| Locked | Locked | Locked |
Respiratory diagnostic and monitoring devices are developed and supplied.
|
|
| Locked | Locked | Locked |
AI-enabled digital stethoscopes for lung sound analysis are developed.
|
|
| Locked | Locked | Locked |
Pulmonary function testing device is developed for respiratory diagnostics.
|
|
| Locked | Locked | Locked |
Developer of a medical device for screening lung function
|
|
| Locked | Locked | Locked |
Portable spirometers and accessories for pulmonary testing are supplied.
|
Detailed competitors of Glyconics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glyconics
Complete news archive for Glyconics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glyconics
Glyconics was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Glyconics is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
Glyconics is a funded company, having raised a total of $2.02M across 2 funding rounds to date.
As of Mar 31, 2022, the latest employee count at Glyconics is 2.
Glyconics was founded in 2013 in Cardiff, United Kingdom, within the medical diagnostics sector. A handheld device employing infrared spectroscopy is utilized to examine sputum samples for biomarkers linked to Chronic Obstructive Pulmonary Disease (COPD) and diabetes. Operations focus on respiratory disorder diagnostics through this targeted technology, supporting clinical applications in healthcare settings.
Glyconics's top competitors include Caltech Innovations, Respiratory Motion and Vitalograph.
Glyconics has 4 investors. Key investors include UK Research and Innovation, WealthClub, Deepbridge Capital, and Boundary Capital Partners.